Landscape of Immune Cell–Type–Specific Transcriptomic and Splicing Regulation in Tuberculosis Revealed by Smart Sequencing

Authors:

Abstract
Understanding how immune cell programs diverge between active tuberculosis (TB) and latent tuberculosis infection (LTB) is essential for improving diagnosis and treatment. Here, we performed a large-scale, full-length, splicing-resolved transcriptomic analysis across 16 purified immune cell types using mini-bulk RNA sequencing. The dataset comprised 2,578 profiles from 43 TB patients, 11 individuals with LTB, and 31 healthy controls, together with longitudinal follow-up data from 10 TB patients during treatment. Analysis of immune cell composition identified increased frequencies of granulocytes, intermediate monocytes, Th17 cells, and regulatory T cells in active TB compared with healthy controls. Beyond cellular composition, alternative splicing (AS) emerged as a major regulatory layer, with T cell subsets exhibiting extensive splicing alterations both during disease and following treatment. Distinct cell-type-specific splicing signatures differentiated TB from LTB, including differential isoform usage of IFNGR1, guanylate-binding proteins, caspases, and gasdermin D along interferon-γ and cell-death-related pathways. These splicing alterations were partially reversed during anti-TB treatment, indicating dynamic regulation linked to disease state. Together, this study defines a splicing-resolved, cell-type-specific immune landscape of TB and reveals AS as a key regulatory mechanism shaping immune dysfunction and recovery during infection and treatment immune.